|
Heron Therapeutics Inc (NASDAQ: HRTX) |
|
Heron Therapeutics Inc
HRTX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Heron Therapeutics Inc growth rates, revenue grew
by 12.33 % in the first quarter of 2025 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 4.5 %
Heron Therapeutics Inc realized net income compared to net loss a year ago in first quarter of 2025
• More on HRTX's Growth
|
|
Heron Therapeutics Inc realized a net loss in trailing twelve months.
Heron Therapeutics Inc realized cash reduction of $ -0.01 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.5.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.
• More on HRTX's Valuation
|
|
|
|
|
Heron Therapeutics Inc realized net loss in trailing twelve months.
Heron Therapeutics Inc realized cash outflow of $ -0.01per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.5.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.
• More on HRTX's Valuation
|
|
HRTX's Profitability Comparisons
|
Heron Therapeutics Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 8.2 % from 10.04 % in IV. Quarter.
Heron Therapeutics Inc net profit margin of 6.85 % is currently ranking no. 42 in Major Pharmaceutical Preparations industry, ranking no. 104 in Healthcare sector and number 1277 in S&P 500.
Profitability by Segment |
Total |
6.85 % |
|
|
Heron Therapeutics Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 8.2 % from 10.04 % in IV. Quarter.
Heron Therapeutics Inc net profit margin of 6.85 % is currently ranking no. 42 in Major Pharmaceutical Preparations industry, ranking no. 104 in Healthcare sector and number 1277 in S&P 500.
• More on HRTX's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com